Literature DB >> 26291410

Rethinking the Standard for Ductal Carcinoma In Situ Treatment.

Laura Esserman1, Christina Yau1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26291410     DOI： 10.1001/jamaoncol.2015.2607

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  30 in total

1.  Response to Laine et al.

Authors:  Peter D R Higgins
Journal:  Am J Gastroenterol       Date:  2015-12       Impact factor: 10.864

2.  Has screening mammography become obsolete?

Authors:  M E Costanza
Journal:  Curr Oncol       Date:  2015-10       Impact factor: 3.677

Review 3.  A Framework for the Development and Interpretation of Different Sepsis Definitions and Clinical Criteria.

Authors:  Derek C Angus; Christopher W Seymour; Craig M Coopersmith; Clifford S Deutschman; Michael Klompas; Mitchell M Levy; Gregory S Martin; Tiffany M Osborn; Chanu Rhee; R Scott Watson
Journal:  Crit Care Med       Date:  2016-03       Impact factor: 7.598

4.  3D Supine Automated Ultrasound (SAUS, ABUS, ABVS) for Supplemental Screening Women with Dense Breasts.

Authors:  Alexander Mundinger
Journal:  J Breast Health       Date:  2016-04-01

5.  Collagen Alignment as a Predictor of Recurrence after Ductal Carcinoma In Situ.

Authors:  Matthew W Conklin; Ronald E Gangnon; Brian L Sprague; Lisa Van Gemert; John M Hampton; Kevin W Eliceiri; Jeremy S Bredfeldt; Yuming Liu; Nuntida Surachaicharn; Polly A Newcomb; Andreas Friedl; Patricia J Keely; Amy Trentham-Dietz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-11-15       Impact factor: 4.254

6.  Wherein the authors attempt to minimize the confusion generated by their study "Breast cancer mortality after a diagnosis of ductal carcinoma in situ" by several commentators who disagree with them and a few who don't: a qualitative study.

Authors:  S A Narod; H Ahmed; V Sopik
Journal:  Curr Oncol       Date:  2017-08-31       Impact factor: 3.677

7.  A Quantitative Centrosomal Amplification Score Predicts Local Recurrence of Ductal Carcinoma In Situ.

Authors:  Michael S Toss; Guanhao Wei; Jaspreet Kaur; Karuna Mittal; Da Hoon Choi; Brian D Melton; Remus M Osan; Islam M Miligy; Andrew R Green; Emiel A M Janssen; Håvard Søiland; Keerthi Gogineni; Upender Manne; Padmashree Rida; Emad A Rakha; Ritu Aneja
Journal:  Clin Cancer Res       Date:  2020-01-14       Impact factor: 12.531

Review 8.  Advances in Breast MRI in the Setting of Ductal Carcinoma In Situ.

Authors:  Nita Amornsiripanitch; Diana L Lam; Habib Rahbar
Journal:  Semin Roentgenol       Date:  2018-08-30       Impact factor: 0.800

9.  The Dana-Farber CISNET Model for Breast Cancer Screening Strategies: An Update.

Authors:  Sandra J Lee; Xiaoxue Li; Hui Huang; Marvin Zelen
Journal:  Med Decis Making       Date:  2018-04       Impact factor: 2.583

10.  Modeling Ductal Carcinoma In Situ (DCIS): An Overview of CISNET Model Approaches.

Authors:  Nicolien T van Ravesteyn; Jeroen J van den Broek; Xiaoxue Li; Harald Weedon-Fekjær; Clyde B Schechter; Oguzhan Alagoz; Xuelin Huang; Donald L Weaver; Elizabeth S Burnside; Rinaa S Punglia; Harry J de Koning; Sandra J Lee
Journal:  Med Decis Making       Date:  2018-04       Impact factor: 2.583
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.